Belimumab, a BLyS-specific inhibitor, reduces disease activity and severe flares in seropositive SLE patients: BLISS-76 study - van Vollenhoven, RF; Zamani, O; Wallace, DJ (Ann Rheum Dis, 2010)
et al.